Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrest Nicholson Regulatory News (CRST)

Share Price Information for Crest Nicholson (CRST)

Share Price is delayed by 15 minutes
Get Live Data
67.70    -1.50 (-2.17%)
Bid:
67.30
Ask:
67.80
Spread: 0.50 (0.743%)
Market Cap: £173.81m
CRST Live PriceLast checked at - London Stock Exchange

Intraday Crest Nicholson Share Chart

Trading Update

19 Mar 2024 07:00

RNS Number : 3177H
Crest Nicholson Holdings PLC
19 March 2024
 

 

The information contained in this announcement is deemed by the Company to constitute inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014 which forms part of domestic law in the United Kingdom pursuant to the European Union (Withdrawal) Act 2018

Crest Nicholson Holdings plc

 (the 'Group' or 'Crest Nicholson')

 

AGM

Crest Nicholson Holdings plc is holding its Annual General Meeting ('AGM') at 11:00 am today at the Group's Head Office: 500 Dashwood Lang Road, Bourne Business Park, Addlestone, Surrey KT15 2HJ. This trading update is for the period from 1 November 2023 to 15 March 2024. The Company's FY24 year end is on 31 October 2024.

Current trading

The Group has achieved reservations in line with expectations and delivered a year-to-date open market SPOW rate of 0.44, based on 46 outlets, with reduced activity before Christmas and a stronger performance from mid-January. The SPOW rate for the last eight weeks to 15 March 2024 improved to 0.52. Sale prices achieved have been in line with expectations and cancellations remained at normalised levels. Build activity in the sector continued to operate at a lower level which is now resulting in lower labour costs in some areas. Overall build cost inflation has largely stabilised and at a level lower than prior year.

The Group remains focused on improving customer service and since February 2023 has consistently achieved >90% customer satisfaction rating.

The planning system continues to be challenging. Our strong land portfolio with several quality sites acquired last year places us in a favourable position to mitigate planning delays and support future outlet growth.

Farnham and other legacy sites

Construction at the Farnham development and other legacy sites which are still being completed is progressing largely as planned.

Pre 2019 completed sites

Since the publication of the FY23 results, the Group has become aware of certain build defects predominantly on four sites that were completed prior to 2019 when the Group closed its Regeneration and London divisions. These sites will require remediation over the next three years at an estimated cost of up to £15m. As a result, the Board has decided to appoint third party consultants to provide greater assurance on the adequacy of current provisions around these and other sites completed prior to 2019. A further update will be provided at the Group's interim results in June.

Outlook

The Group continues to focus on optimising value and expects FY24 completions to be in the range of 1,800 to 2,000 homes, with completions weighted approximately 35/65% in favour of the second half of the year, reflecting the opening order book and the low level of reservations in the first two months of the financial year. Sales prices are expected to remain stable in FY24. Net debt at the end of February 2024 is tracking lower than expected as a result of lower build and land spend and this trend is expected to continue in the remainder of the financial year.

The person responsible for arranging the release of this announcement on behalf of the Company is Penny Thomas, Group Company Secretary.

For further information, please contact:

Crest Nicholson

Jenny Matthews, Head of Investor Relations +44 (0) 7557 842720

Teneo

James Macey White / Giles Kernick +44 (0) 207 260 2700

19 March 2024

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSTVSITLIS
Date   Source Headline
29th May 202610:34 amRNSADMISSION TO TRADING AND TOTAL VOTING RIGHTS
21st May 20269:52 amRNSHolding(s) in Company
20th May 20262:28 pmRNSHolding(s) in Company
19th May 20267:00 amRNSRevised date for the half year results
12th May 20262:09 pmRNSDirector/PDMR Shareholding
1st May 20264:26 pmRNSHolding(s) in Company
30th Apr 20264:04 pmRNSADMISSION TO TRADING AND TOTAL VOTING RIGHTS
28th Apr 20262:56 pmRNSDirector/PDMR Shareholding
24th Apr 20264:47 pmRNSDirector/PDMR Shareholding
21st Apr 20267:00 amRNSTrading Update
20th Apr 20265:21 pmRNSHolding(s) in Company
10th Apr 20264:14 pmRNSDirector/PDMR Shareholding
7th Apr 20269:57 amRNSAdmission to Trading
31st Mar 20263:23 pmRNSTotal Voting Rights
26th Mar 20263:24 pmRNSDirector/PDMR Shareholding
25th Mar 202611:59 amRNSResult of AGM
25th Mar 20267:00 amRNSTrading Statement
24th Mar 20268:45 amRNSDirector/PDMR Shareholding
10th Mar 20264:40 pmRNSDirector/PDMR Shareholding
10th Mar 20264:40 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:22 pmRNSDirector/PDMR Shareholding
27th Feb 20262:37 pmRNSTotal Voting Rights
17th Feb 202610:38 amRNSAnnual Report & Notice of AGM
10th Feb 20265:04 pmRNSDirector/PDMR Shareholding
30th Jan 20262:11 pmRNSTotal Voting Rights
29th Jan 20267:00 amRNSFinal Results
12th Jan 20265:02 pmRNSDirector/PDMR Shareholding
23rd Dec 20253:46 pmRNSTotal Voting Rights
23rd Dec 20253:46 pmRNSTotal Voting Rights
10th Dec 20254:07 pmRNSDirector/PDMR Shareholding
5th Dec 202510:22 amRNSDirector Declaration
28th Nov 20252:55 pmRNSTotal Voting Rights
19th Nov 202512:59 pmRNSHolding(s) in Company
18th Nov 20257:00 amRNSTrading Statement
11th Nov 202512:32 pmRNSDirector/PDMR Shareholding
5th Nov 202510:40 amRNSHolding(s) in Company
31st Oct 20255:07 pmRNSTotal Voting Rights
28th Oct 202511:06 amRNSHolding(s) in Company
28th Oct 202510:02 amRNSDirectorate Change
24th Oct 20253:05 pmRNSHolding(s) in Company
17th Oct 202510:08 amRNSBlock listing Interim Review
10th Oct 20254:21 pmRNSDirector/PDMR Shareholding
30th Sep 202512:07 pmRNSTotal Voting Rights
22nd Sep 20252:48 pmRNSHolding(s) in Company
11th Sep 20254:07 pmRNSDirector/PDMR Shareholding
3rd Sep 20253:48 pmRNSHolding(s) in Company
29th Aug 20251:28 pmRNSTotal Voting Rights
13th Aug 20259:58 amRNSDirector/PDMR Shareholding
1st Aug 20254:46 pmRNSHolding(s) in Company
31st Jul 20252:10 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.